Title : A multi-parametric imaging investigation of the response of C6 glioma xenografts to MLN0518 (tandutinib) treatment.

Pub. Date : 2013

PMID : 23638177






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MLN0518 (tandutinib) is a potent inhibitor of type III receptor tyrosine kinases that demonstrates activity against PDGFRalpha/beta, FLT3 and c-KIT. tandutinib KIT proto-oncogene receptor tyrosine kinase Mus musculus